According to our (Global Info Research) latest study, the global Self Monitoring Blood Glucose (SMBG) Device market size was valued at US$ 17600 million in 2025 and is forecast to a readjusted size of US$ 31940 million by 2032 with a CAGR of 9.0% during review period.
Self-monitoring blood glucose (SMBG) device refers to portable instruments that can identify the possibilities of diabetes. These devices usually measure glucose levels by obtaining a small drop of blood from patients by pricking their fingers. International guidelines recommend this method for managing a patient’s diabetes successfully. The self-monitoring blood glucose (SMBG) device are used to measure the concentration of glucose in the blood.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Self Monitoring Blood Glucose (SMBG) Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Self Monitoring Blood Glucose (SMBG) Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Self Monitoring Blood Glucose (SMBG) Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Self Monitoring Blood Glucose (SMBG) Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Self Monitoring Blood Glucose (SMBG) Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Self Monitoring Blood Glucose (SMBG) Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Self Monitoring Blood Glucose (SMBG) Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bionime Corporation, B.Braun Melsungen AG, F.Hoffmann-La Roche Ltd., LifeScan Inc., PHC Holdings Corporation, Home Diagnostics Inc., Terumo Pharmaceutical Solutions, ARKRAY Inc., Ypsomed Holding AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Self Monitoring Blood Glucose (SMBG) Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Self-Monitoring Blood Glucose Meters
Continuous Glucose Monitors
Testing Strips
Lancets
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Diabetes Clinic
Major players covered
Abbott Laboratories
Bionime Corporation
B.Braun Melsungen AG
F.Hoffmann-La Roche Ltd.
LifeScan Inc.
PHC Holdings Corporation
Home Diagnostics Inc.
Terumo Pharmaceutical Solutions
ARKRAY Inc.
Ypsomed Holding AG
Dexcom Inc.
Medtronic PLC.
Novo Nordisk
Glysens Incorporated
Senseonics Holdings
Ascensia
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Self Monitoring Blood Glucose (SMBG) Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Self Monitoring Blood Glucose (SMBG) Device, with price, sales quantity, revenue, and global market share of Self Monitoring Blood Glucose (SMBG) Device from 2021 to 2026.
Chapter 3, the Self Monitoring Blood Glucose (SMBG) Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Self Monitoring Blood Glucose (SMBG) Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Self Monitoring Blood Glucose (SMBG) Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Self Monitoring Blood Glucose (SMBG) Device.
Chapter 14 and 15, to describe Self Monitoring Blood Glucose (SMBG) Device sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Self Monitoring Blood Glucose (SMBG) Device. Industry analysis & Market Report on Self Monitoring Blood Glucose (SMBG) Device is a syndicated market report, published as Global Self Monitoring Blood Glucose (SMBG) Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Self Monitoring Blood Glucose (SMBG) Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.